VNDA

NASDAQStock

Vanda Pharmaceuticals Inc.

$9.44+0.15 (+1.61%)

52-Week Range

$3.92

$9.56

Key Stats

Market Cap

558.0M

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.61

Volume

1.2M

Avg Volume

5.7M

Performance

+25.20%

+49.12%

+112.10%

YTD

+12.61%

+87.68%

+49.60%

-47.69%

Price Chart

ETF Exposure

VNDA is held by 61 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VTHR	Vanguard Russell 3000 ETF	0.00%	3,703	$28K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	1,761,840	$13.3M	$2.10T	0.03%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	5	$44	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	15	$146	$81.5M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	26	$250	$81.7M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	30	$287	$64.1M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	36	$340	$59.0M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	30	$283	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	20	$187	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	15	$141	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	7	$62	$9.5M	0.12%

PreviousPage 2 of 2

About VNDA ETF Exposure

Vanda Pharmaceuticals Inc. (VNDA) is held by 61 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 558.0M, VNDA is a widely held institutional stock. The stock currently trades at $9.44. Investors can gain exposure to VNDA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold VNDA, sorted by portfolio weight.